Design Therapeutics, Inc. (DSGN) — 8-K Filings

8-K Filings (5)

• Design Therapeutics Reports Officer Changes — Apr 1, 2026 Risk: medium
  Design Therapeutics, Inc. filed an 8-K on April 1, 2026, reporting a departure of a director or certain officer, election of directors, or appointment of certai
• Design Therapeutics Reports Officer and Director Changes — Sep 10, 2025 Risk: medium
  Design Therapeutics, Inc. filed an 8-K on September 10, 2025, reporting changes effective September 9, 2025. The filing indicates a departure of directors or ce
• Design Therapeutics Reports on Shareholder Vote Matters — Jun 12, 2025 Risk: low
  Design Therapeutics, Inc. filed an 8-K on June 12, 2025, reporting on matters submitted to a vote of its security holders on June 10, 2025. The filing details t
• Design Therapeutics Files 8-K — Jan 13, 2025 Risk: low
  On January 13, 2025, Design Therapeutics, Inc. filed an 8-K report. The filing primarily serves as a notification of financial statements and exhibits, and a Re
• Design Therapeutics Files 8-K on Shareholder Votes — Jun 17, 2024 Risk: low
  Design Therapeutics, Inc. filed an 8-K on June 17, 2024, reporting on matters submitted to a vote of security holders as of June 13, 2024. The filing details th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX